CARDINAL HEALTHCARE recalls Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharma
Recalled January 3, 2024 · FDA recall D-0189-2024 · CARDINAL HEALTHCARE
Hazard
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. · FDA Class II
Units
1 unit
Sold at
Nationwide USA
Description
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Product
Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01
Manufacturer(s)
CARDINAL HEALTHCARE
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →